Skip Ribbon Commands
Skip to main content
Menu
Dr  Martin Putera

Dr Martin Putera

​MD (S’pore), MRCP (UK), MMed (Int Med)

Associate Consultant

Sengkang General Hospital

Specialty: Gastroenterology & Hepatology

Conditions Treated by this Doctor:
Colorectal Cancer Screening, Diagnosis and Treatment of Gastrointestinal Liver and Pancreatico-biliary Cancers, Irritable Bowel Syndrome, Liver Diseases (i.e. Viral Hepatitis, Fatty Liver, Alcoholic Liver Disease, Cirrhosis and Portal Hypertensions).

Clinical Appointments

  • Associate Consultant Gastroenterology and Hepatology Service Sengkang General HospitalSengkang General Hospital
  • Associate Consultant Department of General Medicine Sengkang General HospitalSengkang General Hospital

Profile

​Dr Martin Putera received his medical degree from Duke-NUS Graduate Medical School, Singapore. He completed his training in Singhealth Internal Medicine residency and obtained Membership of Royal College of Physician of the United Kingdom (MRCP, UK) and Master of Medicine (MMed). He then completed training in SingHealth Gastroenterology Senior Residency and obtained Singapore Accreditation Board (SAB) certification as specialist in Gastroenterology and Hepatology.

Education

  • ​Doctor of Medicine (MD), Duke-NUS Graduate Medical School, Singapore
  • Master of Medicine (Int Med), National University of Singapore
  • Membership of the Royal College of Physicians of the United Kingdom
  • Singapore Accreditation Board in Gastroenterology

Professional Appointments and Committee Memberships

  • ​Member, Royal College of Physician (UK)
  • Member, American Society of Gastrointestinal Endoscopy
  • Member, American College of Gastroenterology

Awards

​SingHealth RiSE Outstanding Resident award (2022)

Research Interests

Publications

  • ​Wong YJ, Li J, Liu C, Chen Z, Chan YH, Putera M, Teh KB, Ang TL, Zhao L, Yan Z, Kumar R, Li X, Qi X. CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study. J Gastroenterol Hepatol. 2022 Jun;37(6):1043-1051.
  • Putera M, Teh KB, Kumar R, Wong YJ. Small esophageal varices in compensated cirrhosis patients: to treat or not to treat? J Hepatol. 2021 Aug;75(2):491-492.
  • Wong YJ, Kew GS, Tan PS, Chen Z, Putera M, Yip WA, Ang TL, Fock KM, Lee GH, Hsiang J, Huang DQ, Kwek A, Muthiah MD, Kumar R, Tan M, Tan J, Thurairajah PH, Teo EK, Tai BC, Lim SG. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study. Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101598.
  • Putera M, Tan CK, Wong YJ, Kumar R. Higher mortality in acute variceal haemorrhage: Is fresh frozen plasma alone to be blamed? Liver Int. 2021 Aug;41(8):1977-1978.
  • Putera M, Roark R, Lopes RD, Udayakumar K, Peterson ED, Califf RM, Shah BR.Translation of acute coronary syndrome therapies: from evidence to routine clinical practice. Am Heart J. 2015 Feb;169(2):266-73.

Research Trials